Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Piper Sandler raised its price target on GE HealthCare to $94 from $91 and maintained an Overweight rating, pointing to healthy margins, mid-single-digit order growth, and an undemanding valuation. The move comes ahead of the company's January 30 earnings report and amid market uncertainty tied to Flyrcado guidance and other recent developments fro…
Piper Sandler increased its price objective for VF Corp. to $18.00 from $14.00 while leaving the stock at a Neutral rating. The revision follows an investor meeting with senior management and VF's fiscal third-quarter earnings beat, though the updated target remains below the company's current trading price of $20.11. The firm noted stronger digita…
Piper Sandler has reaffirmed an Overweight rating on NovoCure Ltd. (NASDAQ: NVCR) and set a $27.00 price target, implying more than 118% upside from the stock's then-current price of $12.38. InvestingPro analysis flagged the shares as appearing undervalued based on a Fair Value assessment. The research note highlights strategic and messaging adjust…
Kazia Therapeutics Ltd ADR (NASDAQ:KZIA) saw its stock climb 2.5% in premarket trading after releasing preclinical results for NDL2, a protein degrader aimed at nuclear PD-L1. In models of triple-negative breast cancer, NDL2 cut primary tumor volume substantially as a single agent and showed greater reductions when paired with anti-PD-1 therapy, al…
Franklin Resources reported a substantial increase in first-quarter profit as elevated equity markets pushed investment management fees higher. The firm reported $255.5 million in quarterly profit on rising assets under management and meaningful net inflows, prompting a modest rise in its share price in premarket trading.
HubSpot (HUBS) has been knocked down after guidance concerns and sector rotation, but the company still generates meaningful free cash flow, carries no debt, and sits at oversold technicals. This trade targets a mid-term rebound while protecting capital with a tight stop under recent lows.
KGHM's stock fell more than 8% on Friday after the Polish copper and silver producer abruptly removed chief executive Andrzej Szydlo and Vice President Piotr Stryczek. Supervisory board member Remigiusz Paszkiewicz has been appointed acting CEO. Morgan Stanley called the move a "negative surprise" and highlighted uncertainty around the company's ne…
KeyBanc Capital Markets raised its price target on Modine Manufacturing to $205 from $175 while keeping an Overweight rating, citing the company’s plan to spin off its Performance Technologies (PT) division and stronger-than-expected prospects for its Data Center business. The firm revised estimates higher on a 'higher DC trajectory' and highlighte…
KeyBanc has reduced its 12-month price objective for AppFolio to $255 from $270 but left its Overweight recommendation intact. The move follows the company’s fourth-quarter report showing accelerating revenue and unit growth and an earnings-per-share beat, even as initial 2026 revenue guidance fell short of market expectations. The target cut prima…
KeyBanc Capital Markets increased its price target on Parker-Hannifin to $1,100 from $1,050 and kept an Overweight rating following the company's fiscal second-quarter 2026 results. The move reflects what the firm described as continued strong execution against a choppy end-market backdrop outside aerospace, with the company reporting adjusted Q2 E…
KeyBanc Capital Markets left its Sector Weight rating on Apple following the company’s fiscal first-quarter 2026 report, citing strong operational results but a valuation it views as full and expectations for slower growth. The quarter delivered sizable iPhone revenue gains, earnings-per-share acceleration and guidance above consensus, while margin…
KeyBanc Capital Markets raised its price target on ResMed to $302 from $299 and kept an Overweight rating after the company's fiscal second-quarter 2026 results. The firm cited revenue outperformance led by Masks & Accessories and Devices, an improved gross margin outlook, and a robust balance sheet. ResMed reported EPS of $2.81 versus $2.73 expect…
Canada's real gross domestic product was essentially flat in November after a 0.3% decline in October, as a 1.3% fall in manufacturing and a 2.1% drop in wholesale trade offset expansions in retail sales, public sector activity and transportation. Early December data point to a 0.1% rise, but the quarter likely recorded a 0.1% contraction, leaving …
This report catalogues the most notable insider transactions disclosed on Thursday, January 29, 2026. Key highlights include a large purchase by a USA Rare Earth director, additional buys by company insiders and large shareholders at Under Armour and ASA Gold & Precious Metals Ltd, and sizeable sales by executives at Microchip Technology, Micro…
Parke Bancorp President and CEO Pantilione Vito S. bought 1,000 shares of common stock on January 29, 2026, at $27.63 per share for a total of $27,630. The purchase increases his direct shareholdings and sits alongside a portfolio of indirect holdings, options and restricted stock units. Separately, the New Jersey-based bank announced a $0.18 per-s…
Morgan Stanley reduced its price target on Lennox International to $450 from $475 and kept an Underweight rating following the company’s Q4 2025 results. The firm pointed to ongoing volume softness, weak end-market demand, under-absorption risk and pricing pressure as drivers for the lower valuation. Morgan Stanley’s forecasts for 2026 and Q1 2026 …
Keefe, Bruyette & Woods trimmed its 12-month price target for Progressive Corp. to $225 from $252, a 10.7% reduction, while retaining a Market Perform rating. KBW analyst Meyer Shields cited moderating auto policies in force as the primary driver of the revision. The move comes amid a range of analyst views on Progressive, including recent actions …
Keefe, Bruyette & Woods raised its price target on Civista Bancshares to $28 from $27 and retained an Outperform rating after the bank posted stronger-than-expected fourth-quarter operating results and reported higher reported EPS and revenue. The research firm noted benefits across core revenue lines and a slimmer-than-anticipated provision, while…
Stifel has downgraded Unite Group (UTG) from Buy to Hold and reduced its price objective to 600p from 975p, citing weaker-than-expected sales momentum for the upcoming academic year and lower occupancy assumptions after the Empiric acquisition. The broker expects limited dividend growth over its forecast period and models the shares trading at a 6.…
Kepler Cheuvreux has moved Derwent London from Buy to Hold while retaining a 2,050p price target. The broker pointed to a 17% share rally since September and the uncertainty created by the company's announced CEO retirement as reasons for the downgrade. Kepler kept its forecasts and target methodology unchanged, noting limited upside from the curre…
Atlanta Fed President Raphael Bostic told CNBC that the Federal Reserve should adopt a patient stance on interest rates while remaining alert to inflationary pressures. He said there are "ways to go on inflation," expects tariff impacts to show up in the first half of 2026, and wants clear evidence of a return to 2% inflation before altering policy…
Bernstein increased its price target on IBM to $330 from $280 and kept a Market Perform rating after stronger-than-expected fourth-quarter results. IBM exceeded consensus on revenue, earnings per share and free cash flow, provided FY26 guidance that includes more than 5% constant-currency revenue growth and forecasted margin and cash-flow improveme…
Bernstein SocGen Group lowered its price target on United Rentals (URI) to $965 from $1,128 and kept an Outperform rating after the company reported fourth-quarter EBITDA that was slightly below expectations and issued 2026 EBITDA guidance below consensus. Investors focused on sustained margin compression, driving a sharp share decline, even as val…
Bernstein SocGen has reaffirmed an Outperform rating and a $405.00 price target on UnitedHealth Group (UNH) after the shares plunged about 20% in the wake of Medicare Advantage advance rate announcements and the company’s fourth-quarter results. Analyst Lance Wilkes outlined five principal investor concerns, and Bernstein adjusted its model to acco…
Bernstein raised its 12-month price target on RTX Corp. to $204 from $189 while retaining a Market Perform designation, pointing to stronger-than-expected results in the Raytheon segment. RTX recently posted quarterly and full-year beats, a rising backlog at Raytheon and several sizable contract awards, but the firm signaled ongoing concerns around…
